Market›Health Care›Biotechnology›Biotechnology
NEXTCURE INC

NXTC

$10.52Apr 26, 2021 – Apr 24, 2026
Health CareBiotechnology$40M
MVM
-$0.2M
TD Variance
-13.600

Every news event mapped to its market reaction — 78 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-10-16+75.3%newsSeeking AlphaNextCure and Simcere expand SIM0505 trial to the U.S.
2024-03-21+34.6%earningsSeeking AlphaNextCure GAAP EPS of -$2.25 beats by $0.02
2024-03-21+34.6%legalSEC EDGARNXTC 8-K: 2.02, 7.01 (SEC Filing)
2022-11-04-34.3%newsSeeking AlphaNextCure (NXTC) Investor Presentation - Slideshow
2025-06-16-33.7%legalSEC EDGARNXTC 8-K: 1.01, 3.02, 7.01, 8.01 (SEC Filing)
2023-12-14-23.2%newsSeeking AlphaNextCure stock falls 20% amid program shutdown, business update
2022-11-03-20.2%earningsSeeking AlphaNextCure GAAP EPS of -$0.68 misses by $0.02
2022-11-03-20.2%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2025-07-10-12.2%legalSEC EDGARNXTC 8-K: 8.01 (SEC Filing)
2025-07-10-12.2%newsInvesting.comNextCure announces 1-for-12 reverse stock split effective July 14 - Investing.com
2021-09-30+10.7%newsSeeking AlphaSA PRO Editors: NextCure - 100%+ Upside
2022-08-04+10.0%earningsSeeking AlphaNextCure GAAP EPS of -$0.65 beats by $0.09
2022-08-04+10.0%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2022-08-05+9.8%newsSeeking AlphaNextCure (NXTC) Investor Presentation - Slideshow
2024-05-02+9.5%earningsSeeking AlphaNextCure GAAP EPS of -$0.61 misses by $0.15
2024-05-02+9.5%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2022-11-15-7.8%newsSeeking AlphaNextCure, South Korea's LegoChem Biosciences to develop antibody drug conjugates
2023-11-02+7.4%earningsSeeking AlphaNextCure GAAP EPS of -$0.51
2023-11-02+7.4%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2025-01-10-7.2%legalSEC EDGARNXTC 8-K: 8.01 and (SEC Filing)
2025-05-01-6.9%earningsSeeking AlphaNextCure GAAP EPS of -$0.39
2025-05-01-6.9%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2023-03-02-6.9%earningsSeeking AlphaNextCure GAAP EPS of -$2.69 misses by $0.04
2023-03-02-6.9%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2025-12-19+6.8%legalSEC EDGARNXTC 8-K: 8.01 and (SEC Filing)
2025-08-08-6.4%earningsSeeking AlphaNextCure GAAP EPS of -$11.29
2025-08-07-6.3%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2025-05-29+5.1%newsIntellectia AINXTC Forecast — Price Prediction for 2026. Should I Buy NXTC? - Intellectia AI
2025-05-29+5.1%newsStock TitanFirst-in-Human Trial: NextCure's Revolutionary Cancer Drug Shows Promise Against 5 Hard-to-Treat Tumors - Stock Titan
2021-08-05+5.0%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2024-06-18+4.9%legalSEC EDGARNXTC 8-K: 5.02 and (SEC Filing)
2022-10-18-4.2%analystZacks Investment ResearchWhat is the current Price Target and Forecast for NextCure (NXTC) - Zacks Investment Research
2026-01-23-4.1%legalSEC EDGARNXTC 8-K: 2.02, 7.01, 8.01 (SEC Filing)
2021-10-04+4.0%legalSEC EDGARNXTC 8-K: 5.02, 7.01 (SEC Filing)
2022-02-25-3.9%newsSeeking AlphaNextCure (NXTC) Presents At Global Healthcare Virtual Conference - Slideshow
2023-06-02+3.7%newsSeeking AlphaNextCure (NXTC) Presents At Life Sciences Conference - Slideshow
2023-05-04+3.5%earningsSeeking AlphaNextCure GAAP EPS of -$0.58 beats by $0.04
2023-05-04+3.5%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2024-03-26-3.4%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2022-06-15-3.3%newsSeeking AlphaNextCure (NXTC) Investor Presentation - Slideshow
2024-12-10-3.0%legalSEC EDGARNXTC 8-K: 8.01 and (SEC Filing)
2025-11-17+3.0%legalSEC EDGARNXTC 8-K: 1.01, 3.02, 7.01, 8.01 (SEC Filing)
2026-03-31+2.7%newsGlobeNewswireNextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
2026-03-31+2.7%newsStock TitanPhase 1 cancer drug abstract lands ASCO 2026 slot in Chicago - Stock Titan
2025-11-05+2.6%earningsSeeking AlphaNextCure GAAP EPS of -$3.22
2025-11-05+2.6%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2025-03-06+2.6%earningsSeeking AlphaNextCure GAAP EPS of -$1.99
2025-03-06+2.6%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2024-11-08+2.5%earningsSeeking AlphaNextCure GAAP EPS of -$0.41
2026-04-08-2.4%newsCổng thông tin điện tử tỉnh Tây NinhIs NextCure (NXTC) Stock heavily shorted | Price at $12.10, Up 8.67% - Real Time Stock Idea Network - Cổng thông tin điện tử tỉnh Tây Ninh
2026-04-03+2.4%newsXã Thanh HàNXTC Stock Analysis: NextCure Inc. Biotech Gains 1.80 Percent to 10.72 Support Level - Xã Thanh Hà
2021-09-16-2.4%newsSeeking AlphaNextCure (NXTC) Presents At H. C. Wainwright 23rd Annual Global Investment Conference - Slideshow
2024-11-07-2.4%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2023-07-19-2.3%legalSEC EDGARNXTC 8-K: 5.02 (SEC Filing)
2026-04-21+2.2%newsGlobeNewswireNextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
2021-11-04-2.2%earningsSeeking AlphaNextCure EPS beats by $0.02
2021-11-04-2.2%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2023-08-03-2.1%earningsSeeking AlphaNextCure GAAP EPS of -$0.64 misses by $0.05
2023-08-03-2.1%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2024-08-01+2.0%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2021-05-06+1.8%legalSEC EDGARNXTC 8-K: 8.01 and (SEC Filing)
2025-08-25+1.8%legalSEC EDGARNXTC 8-K: 5.02 (SEC Filing)
2026-01-03+1.7%newsAD HOC NEWSThe Truth About NextCure Inc (NXTC): Hidden Biotech Underdog or Total Flop Stock? - AD HOC NEWS
2026-03-06-1.5%earningsSeeking AlphaNextCure GAAP EPS of -$19.65
2024-08-02-1.5%earningsSeeking AlphaNextCure GAAP EPS of -$0.55 misses by $0.17
2026-04-07-1.4%newsGlobeNewswireNextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
2026-04-07-1.4%legalStock TitanFDA fast-tracks NextCure ovarian cancer drug ahead of ASCO data - Stock Titan
2021-09-24+1.0%legalSEC EDGARNXTC 8-K: 5.02 (SEC Filing)
2025-07-14+0.7%newsInvesting.comNextCure initiates one-for-twelve reverse stock split on Nasdaq - Investing.com
2022-05-05-0.4%earningsSeeking AlphaNextCure GAAP EPS of -$0.74 misses by $0.07
2022-05-05-0.4%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2026-03-05+0.2%newsGlobeNewswireNextCure Provides Business Update and Reports Full Year 2025 Financial Results
2026-03-05+0.2%legalSEC EDGARNXTC 8-K: 2.02 and (SEC Filing)
2022-03-03-0.1%earningsSeeking AlphaNextCure GAAP EPS of -$2.51
2022-03-03-0.1%legalSEC EDGARNXTC 8-K: 2.02, 7.01 (SEC Filing)
2021-09-29-0.1%newsSeeking AlphaNextCure: Large Upside With Downside Protected By Cash Pile
2023-05-05+0.0%newsSeeking AlphaNextCure (NXTC) Investor Presentation - Slideshow
2026-04-24—newsStock TitanNextCure (NASDAQ: NXTC) plans 2026 meeting, auditor, pay and equity plan votes - Stock Titan
tickerdossier.comtickerdossier.substack.com